A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
NOT ENROLLING
Trial ID:
NCT04009109 Protocol # :
20-074
Phase
II
Disease Sites
Multiple Myeloma
Principal Investigator
Yee, Andrew
Site Research Nurses
Gammon, Marilyn
Serino-Cipoletta, Jessica
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #20-074
20-074